XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Sep. 30, 2020 $ 5,144 $ 275,548,737 $ (269,835,650) $ (8,725) $ 5,709,506
Balance (in shares) at Sep. 30, 2020 5,142,779        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants $ 519 2,605,010     2,605,529
Exercise of warrants (in shares) 518,551        
Fair value of warrants issued in connection with convertible note repayment   1,643,440     1,643,440
Stock based compensation expense   571,498     571,498
Net loss     (4,809,556) 2,494 (4,807,062)
Balance at Dec. 31, 2020 $ 5,663 280,368,685 (274,645,206) (6,231) 5,722,911
Balance (in shares) at Dec. 31, 2020 5,661,330        
Balance at Sep. 30, 2021 $ 7,488 295,228,272 (284,122,092) (722) $ 11,112,946
Balance (in shares) at Sep. 30, 2021 7,486,120       7,486,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense   1,699,920     $ 1,699,920
Options issued in settlement of accrued bonus   300,000     300,000
Net loss     (4,721,766) 855 (4,720,911)
Balance at Dec. 31, 2021 $ 7,488 $ 297,228,192 $ (288,843,858) $ 133 $ 8,391,955
Balance (in shares) at Dec. 31, 2021 7,486,120       7,486,120